We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Hydrogel “Homing Beacon” Recruits Drugs to Tumor Target

News   Jun 13, 2019 | Original story from ACS

 
 Hydrogel “Homing Beacon” Recruits Drugs to Tumor Target

In mice, a hydrogel recruits a dye-labeled molecule (colored areas) to its location, showing its potential for being a “homing beacon” for cancer drugs. Credit: Adapted from ACS Central Science 2019, DOI: 10.1021/acscentsci.9b00195

 
 
 

RELATED ARTICLES

A Sweet Surprise: Targeting Sugar-coated Proteins to Treat Pancreatitis

News

CA19-9 – a complex sugar structure that coats many proteins, has now been linked to the transformation of pancreatitis to pancreatic cancer, according to a new study published in Science.

READ MORE

Uniting CRISPR Pioneers With Industry Experts to Accelerate Drug Discovery

News

GlaxoSmithKline plc (GSK) has launched a five-year, $67 million collaboration with the San Francisco and Berkeley campuses of the University of California to build a state-of-the-art laboratory. The goal is to use CRISPR technologies to explore how genes cause disease and to rapidly accelerate the discovery of new drugs.

READ MORE

Switching Embryonic Stem Cells to Neurons to Expose Drug Effects on the Developing Brain

News

A new experimental system has been designed that can rapidly assess the pathogenic effects of a drug on a baby's developing brain. The system uses embryonic stem cells reprogrammed into neurons, and offers a powerful tool for probing genetic and molecular underpinnings of drug-induced neurodevelopmental disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE